Jack Meehan
Stock Analyst at Barclays
(3.10)
# 1,123
Out of 4,874 analysts
136
Total ratings
70.73%
Success rate
21.1%
Average return
Main Sectors:
Stocks Rated by Jack Meehan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LH Labcorp Holdings | Maintains: Equal-Weight | $250 → $275 | $259.13 | +6.12% | 16 | Jun 25, 2025 | |
| A Agilent Technologies | Maintains: Underweight | $120 → $125 | $119.91 | +4.24% | 20 | Feb 28, 2024 | |
| WAT Waters | Maintains: Equal-Weight | $275 → $288 | $354.50 | -18.76% | 10 | Aug 3, 2023 | |
| AVTR Avantor | Initiates: Overweight | $33 | $13.81 | +138.96% | 3 | Mar 3, 2021 | |
| ILMN Illumina | Initiates: Underweight | $325 | $94.96 | +242.25% | 8 | Mar 3, 2021 | |
| INMD InMode | Maintains: Overweight | $18 → $19 | $14.15 | +34.32% | 3 | Aug 17, 2020 | |
| DGX Quest Diagnostics | Maintains: Equal-Weight | $93 → $99 | $178.45 | -44.52% | 7 | Apr 23, 2020 | |
| ICLR ICON Public Limited Company | Maintains: Overweight | $170 → $180 | $146.55 | +22.82% | 2 | Apr 23, 2020 | |
| MYGN Myriad Genetics | Maintains: Underweight | $14 → $10 | $5.31 | +88.32% | 8 | Mar 26, 2020 | |
| IQV IQVIA Holdings | Maintains: Overweight | $192 → $166 | $159.31 | +4.20% | 4 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $51 → $43 | $64.77 | -33.61% | 9 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $170 → $154 | $152.49 | +0.99% | 7 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $435 → $430 | $244.44 | +75.91% | 6 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $435 → $430 | $242.60 | +77.25% | 6 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | n/a | $28.43 | - | 10 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $52 → $48 | $42.52 | +12.89% | 4 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $720 → $680 | $1,204.06 | -43.52% | 4 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $28 → $30 | $108.36 | -72.31% | 3 | Oct 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $295 → $300 | $412.25 | -27.23% | 5 | Mar 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $40 | $1.51 | +2,549.01% | 1 | Dec 11, 2017 |
Labcorp Holdings
Jun 25, 2025
Maintains: Equal-Weight
Price Target: $250 → $275
Current: $259.13
Upside: +6.12%
Agilent Technologies
Feb 28, 2024
Maintains: Underweight
Price Target: $120 → $125
Current: $119.91
Upside: +4.24%
Waters
Aug 3, 2023
Maintains: Equal-Weight
Price Target: $275 → $288
Current: $354.50
Upside: -18.76%
Avantor
Mar 3, 2021
Initiates: Overweight
Price Target: $33
Current: $13.81
Upside: +138.96%
Illumina
Mar 3, 2021
Initiates: Underweight
Price Target: $325
Current: $94.96
Upside: +242.25%
InMode
Aug 17, 2020
Maintains: Overweight
Price Target: $18 → $19
Current: $14.15
Upside: +34.32%
Quest Diagnostics
Apr 23, 2020
Maintains: Equal-Weight
Price Target: $93 → $99
Current: $178.45
Upside: -44.52%
ICON Public Limited Company
Apr 23, 2020
Maintains: Overweight
Price Target: $170 → $180
Current: $146.55
Upside: +22.82%
Myriad Genetics
Mar 26, 2020
Maintains: Underweight
Price Target: $14 → $10
Current: $5.31
Upside: +88.32%
IQVIA Holdings
Mar 26, 2020
Maintains: Overweight
Price Target: $192 → $166
Current: $159.31
Upside: +4.20%
Mar 26, 2020
Maintains: Equal-Weight
Price Target: $51 → $43
Current: $64.77
Upside: -33.61%
Mar 26, 2020
Maintains: Equal-Weight
Price Target: $170 → $154
Current: $152.49
Upside: +0.99%
Mar 26, 2020
Maintains: Overweight
Price Target: $435 → $430
Current: $244.44
Upside: +75.91%
Mar 26, 2020
Maintains: Overweight
Price Target: $435 → $430
Current: $242.60
Upside: +77.25%
Mar 26, 2020
Downgrades: Equal-Weight
Price Target: n/a
Current: $28.43
Upside: -
Mar 26, 2020
Upgrades: Overweight
Price Target: $52 → $48
Current: $42.52
Upside: +12.89%
Mar 26, 2020
Upgrades: Equal-Weight
Price Target: $720 → $680
Current: $1,204.06
Upside: -43.52%
Oct 2, 2019
Maintains: Underweight
Price Target: $28 → $30
Current: $108.36
Upside: -72.31%
Mar 18, 2019
Maintains: Overweight
Price Target: $295 → $300
Current: $412.25
Upside: -27.23%
Dec 11, 2017
Initiates: Equal-Weight
Price Target: $40
Current: $1.51
Upside: +2,549.01%